Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
VSTM
VSTM
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
VSTM News
Verastem Oncology Appoints New Board Member
5d ago
Newsfilter
Verastem Oncology Announces Investor Conference Schedule
May 12 2026
Newsfilter
Launch of LGSOC Resource Guide to Support Patients
May 08 2026
Newsfilter
Verastem Q1 2026 Earnings Call Insights
May 08 2026
seekingalpha
Verastem Q1 2026 Earnings Beat Expectations
May 07 2026
seekingalpha
Verastem Launches New Treatment for LGSOC
Apr 30 2026
Newsfilter
RAMP 201 Clinical Trial Data Released
Apr 10 2026
Newsfilter
VS-7375 Demonstrates Strong Efficacy in Cancer Models
Mar 17 2026
Newsfilter
Verastem Presents New Data from LGSOC Clinical Trial at SGO 2026
Mar 17 2026
Newsfilter
Verastem Reports Q4 Earnings Beat, Stock Rises
Mar 05 2026
stocktwits
Verastem Q4 2025 Earnings Call Highlights
Mar 05 2026
seekingalpha
Verastem Q4 Earnings Beat Expectations
Mar 04 2026
seekingalpha
Verastem to Announce Q4 Earnings on March 4
Mar 03 2026
seekingalpha
Verastem Oncology to Host Q4 2025 Financial Results Call
Feb 18 2026
Businesswire
Verastem Oncology Schedules Q4 2025 Financial Results Call
Feb 18 2026
Newsfilter
Verastem Projects $17.5 Million Net Revenue for Q4 2025
Feb 04 2026
seekingalpha
Show More News
